safinamide mesylate
Drug Details
- Generic Name
- safinamide mesylate
- Brand Names
- Xadago
- Application Number
- NDA207145
- Sponsor
- MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
- NDC Codes
- 2
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- SAFINAMIDE MESYLATE
Indications and Usage
1 INDICATIONS AND USAGE XADAGO is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off" episodes. XADAGO is a monoamine oxidase type B (MAO-B) inhibitor indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off" episodes ( 1 )